ConductScience.org, home

Paper ยท 17682002

Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.

Kugathasan S and 8 others. Gut, 2007. Cited by 157 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Papers, record 17682002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17682002

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.
PubMed
Journal
Gut
PubMed
Year
2007
PubMed
Publication types
Journal Article, Multicenter Study, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
157
iCite
Relative citation ratio, by iCite
3.31
iCite
Revised in PubMed
2022-03-16
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kugathasan SS
2Saubermann LJL J
3Smith LL
4Kou DD
5Itoh JJ
6Binion DGD G
7Levine ADA D
8Blumberg RSR S
9Fiocchi CC

Source PubMed

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Crohn DiseaseMajor topic
Intestinal MucosaMajor topic
T-Lymphocyte SubsetsMajor topic
Adolescent
Cells, Cultured
Child
Child, Preschool
Colon
Cytokines
Disease Progression
Female
Gene Expression Regulation
Humans
Immunity, Mucosal
Interferon-gamma
Interleukin-10
Interleukin-12 Subunit p40
Interleukin-4
Male
RNA, Messenger
Receptors, Interleukin-12
Th1 Cells

Source PubMed

Grants15

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R37 DK044319NIDDK NIH HHSUnited StatesR01DK044319PubMed and NIHNIH RePORTER
DK51362NIDDK NIH HHSUnited StatesR01DK051362PubMed and NIHNIH RePORTER
DK44319NIDDK NIH HHSUnited StatesR01DK044319PubMed and NIHNIH RePORTER
R01 DK051362NIDDK NIH HHSUnited StatesR01DK051362PubMed and NIHNIH RePORTER
R01 DK054213NIDDK NIH HHSUnited StatesR01DK054213PubMed and NIHNIH RePORTER
P01 DK057756NIDDK NIH HHSUnited StatesP01DK057756PubMed and NIHNIH RePORTER
DK30399NIDDK NIH HHSUnited StatesR01DK030399PubMed and NIHNIH RePORTER
R37 DK030399NIDDK NIH HHSUnited StatesR01DK030399PubMed and NIHNIH RePORTER
R01 DK050984NIDDK NIH HHSUnited StatesR01DK050984PubMed and NIHNIH RePORTER
DK57756NIDDK NIH HHSUnited StatesP01DK057756PubMed and NIHNIH RePORTER

1 to 10 of 15

See all 15 grants

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111,095,340Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease.Am J Gastroenterol2000https://conductscience.org/library/papers/11095340PubMed
214,571,234Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study.J Pediatr2003https://conductscience.org/library/papers/14571234PubMed
316,290,228Understanding the IL-23-IL-17 immune pathway.Trends Immunol2006https://conductscience.org/library/papers/16290228PubMed
49,075,798
Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells.
Diabetes1997https://conductscience.org/library/papers/9075798PubMed
517,635,957Phenotypic and functional features of human Th17 cells.J Exp Med2007https://conductscience.org/library/papers/17635957PubMed
68,786,337IL-12 unmasks latent autoimmune disease in resistant mice.J Exp Med1996https://conductscience.org/library/papers/8786337PubMed
717,101,325Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis.Gastroenterology2006https://conductscience.org/library/papers/17101325PubMed
89,207,269Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease.Gastroenterology1997https://conductscience.org/library/papers/9207269PubMed
916,670,765The IL-23/IL-17 axis in inflammation.J Clin Invest2006https://conductscience.org/library/papers/16670765PubMed
1016,424,940Toll-like receptor 2 controls expansion and function of regulatory T cells.J Clin Invest2006https://conductscience.org/library/papers/16424940PubMed

Cited by61

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 157 citations.

PMIDTitleJournalYearIn PapersSource
42,955,493The Importance of Early (Effective) Interventions in Crohn's Disease: Current Concepts and Emerging Evidence.Curr Gastroenterol Rep2026https://conductscience.org/library/papers/42955493PubMed
42,012,779Interleukin-23 Inhibitors in Inflammatory Bowel Disease.BioDrugs2026https://conductscience.org/library/papers/42012779PubMed
41,465,370T Regulatory Cells in Inflammatory Bowel Disease-Are They Major Players?Int J Mol Sci2025https://conductscience.org/library/papers/41465370PubMed
40,620,305Markers of bacterial translocation as a possible indicator of subclinical inflammation in pediatric inflammatory bowel diseases patients.Prz Gastroenterol2025https://conductscience.org/library/papers/40620305PubMed
38,233,198Fibrosis in IBD: from pathogenesis to therapeutic targets.Gut2024https://conductscience.org/library/papers/38233198PubMed
37,047,398Tobacco Alkaloid Assessment in a DSS-Induced Colitis Mouse Model with a Fully Humanized Immune System.Int J Mol Sci2023https://conductscience.org/library/papers/37047398PubMed
35,553,662IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality.J Crohns Colitis2022https://conductscience.org/library/papers/35553662PubMed
34,995,532The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease.Gastroenterology2022https://conductscience.org/library/papers/34995532PubMed
34,638,616Tumor Necrosis Factor's Pathway in Crohn's Disease: Potential for Intervention.Int J Mol Sci2021https://conductscience.org/library/papers/34638616PubMed
33,993,489Novel mechanisms and clinical trial endpoints in intestinal fibrosis.Immunol Rev2021https://conductscience.org/library/papers/33993489PubMed

1 to 10 of 61

See all 61 cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNG3,458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL12B3,593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene
IL12RB23,595PubTator's text mininghttps://conductscience.org/library/genes/3595NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17682002

GET https://conductscience.org/api/papers/v1/17682002/references?page=2